Notification No. F. 1-2/2022 -CEO-DRAP, dated 2nd March, 2022.
About Us
SRO 406(I)/2022 (Reduction in MRP of Remdesivir 100mg injection)
Area Requirement for Manufacturing Site for Alternative Medicines and Health Products
SRO 219(I)/2022 (Amendment in Schedule-I of DRAP Act, 2012)
SRO 134 (I)/2021 dated 2nd February 2021: Import of Unregistered Drugs for Use in Hospitals and Institutions
The Pharmacovigilance Rules, 2022
Amendments in the Medical Devices Rules, 2017 (SRO 1500 (I) 2021)
S.RO.1500(I)/2021.- In exercise of the powers conferred by section 23 of the Drug Regulatory Authority of Pakistan Act,2012 (XXI of 2012), the Drug Regulatory Authority of Pakistan, with approval of the Federal Government, is pleased to direct that the following amendments shall be made in the Medical Devices Rules, 2017, namely:-
In the aforesaid Rules,-
(a) in rule 6, in sub-rule (l).-
(i) for clause (c), the following shall be substituted, namely;- “(c) the manufacturing shall be conducted under the active supervision of competent technical staff, who shall be in-charge of production, a whole time employee of the manufacturer and having relevant qualification and experience as deemed appropriate by the MDB;”; and
(ii) for clause (e), the following shall be substituted, namely:- “(e) the in-charge of quality control shall be a whole-time employee of the manufacturer and shall possess relevant qualification and experience as deemed appropriate by the MDB;”; and
(b) in rule 63, in sub-rule (3), expression after the words “omit any”, the words “Form or” shall be inserted.
Ethical Marketing to Healthcare Professionals Rules, 2021 (S.R.O. 1472(I)/2021)
The Ethical Marketing to Healthcare Professionals Rules
The Drug Pricing Policy, 2018
Drug Pricing Policy 2018 (as amended)
Drug Pricing Policy, 2018 (as of June 12, 2018)
S.R.O No. 9-13/2016-DDC(P) (issued on January 21, 2019)
S.R.O No. 11-2/2020-DD(P) (issued on July 15, 2020)
S.R.O No. 678(I)/2023 (issued on June 09, 2023)